Physician profile
Mitchell B Miller
NPI 1952451866
$6,649.82
in general payments reported to CMS, 2019-2025
11 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2021: $157 · 2022: $4,348 · 2023: $737 · 2024: $805 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.48 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $4,438.08 | 2022-2024 | Thn Sleep Therapy |
| Inspire Medical Systems, INC. | $1,449.91 | 2021-2025 | Inspire |
| Stryker Corporation | $214.38 | 2023-2025 | Scopis Ent, Fiagon Navigation Unit |
| Neurent Medical Limited | $169.11 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Medtronic, INC. | $128.23 | 2024-2025 | Propel |
| Aerin Medical INC. | $99.44 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $56.01 | 2025 | Dupixent |
| Genzyme Corporation | $53.12 | 2019-2025 | |
| Baxter Healthcare | $26.33 | 2019 | |
| Optinose US, INC. | $15.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.